Korean J Hematol.
1999 May;34(2):317-325.
Effects of Induction Chemotherapy with BHAC Plus Idarubicin on Long-term Survival for Patients with Acute Myelogenous Leukemia according to Different Postremission Strategies
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Acute Myelogenous Leukemia during Pregnancy
- Cytarabine Plus Daunorubicin or Idarubicin as Induction Chemotherapy for the Patients with De novo Acute Myelogenous Leukemia
- Renission induction chemotherapy with idarubicin and cytosine arabinoside for the patients with acute myelogenous leukemia
- Cytarabine and Idarubicin Induction Chemotherapy in Patients with Acute Myelogenous Leukemia
- Treatment of Acute Myelogenous Leukemia in Children: Remission Induction with Adriamycin and Cytosine Arabinoside, and Postremission Maintenance Chemotherapy with Adriamycin, Cytosine Arabinoside and 6-thioguanine
